|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.71 CAD | +0.71% |
|
+0.61% | +13.84% |
| 01-09 | Bright Minds Biosciences Closes its US$175 Million Public Offering | MT |
| 01-09 | Bright Minds Biosciences Closes $175.1 Million Stock Offering | MT |
EPS & Dividend: Bright Minds Biosciences Inc.
| Fiscal Period: September | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.98 | -1.78 | -7.746 | -13.04 | -13.11 |
| Distribution rate | - | - | - | - | - |
| Reference price 2 | 2.15 | 84.39 | 125.71 | 125.71 | 125.71 |
| Nbr of stocks (in thousands) | 3,772 | 7,089 | 9,732 | - | - |
| Announcement Date | 29/12/23 | 24/12/25 | - | - | - |
1CAD in Million2CAD
Estimates
Upcoming events: Bright Minds Biosciences Inc.
| 17/02/2026 | Q1 2026 Earnings Release (Projected) |
| 13/05/2026 | Q2 2026 Earnings Release (Projected) |
| 12/08/2026 | Q3 2026 Earnings Release (Projected) |
| 16/12/2026 | Q4 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| - | - | -16.11x | - | - | ||
| 0.87% | 0.99% | 39.34x | 4.05x | 5.7x | ||
| -.--% | -.--% | 33.91x | 6.46x | 3.36x | ||
| -.--% | -.--% | 102.18x | 9.24x | 6.54x | ||
| 0.34% | 0.35% | 56.5x | 2.7x | 11.6x | ||
| -.--% | -.--% | -20.97x | 14.27x | 6085.09x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 40.48x | 40.42x | 6.56x | ||
| 0.87% | 0.95% | 27.95x | 2.41x | 2.22x | ||
| -.--% | -.--% | 26.74x | 1.47x | 2.08x | ||
| Average | 0.26% | 0.29% | 32.22x | 10.13x | 765.39x | |
| Weighted average by Cap. | 0.3% | 0.33% | 43.32x | 8.59x | 610.17x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















